Alendronate promotes plasmin-mediated MMP-9 inactivation by exposing cryptic plasmin degradation sites within the MMP-9 catalytic domain.
about
Gelatinase B/MMP-9 in Tumour Pathogenesis and ProgressionRegulation and involvement of matrix metalloproteinases in vascular diseasesATIQCTPC targeting MMP-9: a key step to slowing primary tumor growth and inhibiting metastasis of lewis lung carcinoma in vivo.Synergistic effect of photodynamic therapy and alendronate on alveolar bone loss in rats with ligature-induced periodontitis.
P2860
Alendronate promotes plasmin-mediated MMP-9 inactivation by exposing cryptic plasmin degradation sites within the MMP-9 catalytic domain.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Alendronate promotes plasmin-m ...... in the MMP-9 catalytic domain.
@en
Alendronate promotes plasmin-m ...... in the MMP-9 catalytic domain.
@nl
type
label
Alendronate promotes plasmin-m ...... in the MMP-9 catalytic domain.
@en
Alendronate promotes plasmin-m ...... in the MMP-9 catalytic domain.
@nl
prefLabel
Alendronate promotes plasmin-m ...... in the MMP-9 catalytic domain.
@en
Alendronate promotes plasmin-m ...... in the MMP-9 catalytic domain.
@nl
P2093
P2860
P50
P1433
P1476
Alendronate promotes plasmin-m ...... in the MMP-9 catalytic domain.
@en
P2093
Alberto Gulino
Marzia Ragone
Pierdomenico Ruggeri
Stefania Merolle
P2860
P304
P356
10.1016/J.FEBSLET.2012.05.048
P407
P577
2012-06-04T00:00:00Z